John J. Castellani is President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA), an organization that represents America’s leading biopharmaceutical research companies. The biopharmaceutical sector directly employs over 650,000 Americans working to develop new medicines that help patients fight disease and live, longer healthier lives.Read More
The Catalyst Contributors
Authors Contributing to The Catalyst
The Catalyst provides news & commentary on access to life-saving treatments, America’s biopharma industry & researchers’ progress in developing new medicines. Contributors include PhRMA staff & leaders from the industry.
Jon Tripp is Senior Director of Digital Advocacy in the Communications & Public Affairs department at PhRMA where he oversees the organization’s widespread online presence. He came to PhRMA in 2005 after serving as Deputy Communications Director for the U.S. House of Representatives Committee on Energy and Commerce.
Jon enjoys spending every free moment with his wife and three kids - and their King Charles Cavalier (Lady). Despite all the Apple devices he carries on his person, Jon neither works for the retailer nor draws referrals for his ardent support of their products.Read More
Stephanie is a Senior Director of Communications at PhRMA, focusing on science advocacy and regulatory issues. As a rare disease patient and stroke survivor, she is very passionate about the need for public policy that encourages innovation and the development of safe and effective new therapies. In her free time, she is trying her hand at gardening and decorating her relatively-new home. Follow Stephanie on Twitter @SDFatPhRMA and join her in #RarePOV.Read More
Sascha Haverfield is the Vice President for Scientific and Regulatory Affairs at PhRMA. He leads PhRMA's activities on global regulatory policy issues and is the architect of our engagement on the implementation of the Prescription Drug User Fee Act (PDUFA). He previously worked in the biopharmaceutical industry on drug discovery, translational medicine and regulatory affairs with a focus on global drug development issues.Read More
Randy Burkholder is Vice President of Policy and Research at the Pharmaceutical Research and Manufacturers of America. Mr. Burkholder leads PhRMA work on policy solutions for supporting continued biopharmaceutical innovation and high-quality, patient-centered health care, including issues involving comparative effectiveness research, health technology assessment, payment and delivery reform (accountable care organizations and bundled payment policy), appropriate use and patient adherence, and personalized medicine. Mr.Read More
Dr. Bill Chin leads PhRMA’s Scientific & Regulatory Affairs department. A physican, an endocrinologist and an academic at heart, Dr. Chin envisions establishing PhRMA as the premiere convener in advancing drug discovery and development, regulatory sciences and collaborative partnerships.Read More
Christian has been a member of the PhRMA family for 12 years. In that time, he has helped create programs to assist the uninsured and promote the value of innovative jobs. Currently, he proudly leads PhRMA’s social and digital team. When not staring at his computer screen, he’s a devoted dad, struggling pianist and amateur triathlete. Follow Christian on Twitter @CCatPhRMARead More
Kaelan Hollon joined PhRMA in 2007, coming from a public relations firm in Louisville, Kentucky. She previously worked for a small law firm that handled bioethics consulting, and while in Louisville she managed several health care accounts for lobbying and public affairs clients. She graduated from Eastern Kentucky University with a degree in Philosophy and has a J.D. from the University of Kentucky. In her spare time, she competes nationally as a professional boxer. Follow Kaelan on Twitter @KaelanAtPhRMARead More
Josie Martin is Executive Vice President of Public Affairs at PhRMA. In a career spanning over 20 years, she worked on the Senate Finance Committee, The American Red Cross and has touched many facets of healthcare communications, from anti-smoking campaigns and getting America fit to cancer awareness.Read More
Preet Bilinski arrived at PhRMA nine years ago, after graduating from James Madison University. Somehow her degree in Computer Information Systems landed her in the healthcare communications world. She manages the Medicines in Development series, that showcases the hope and promise of innovative treatments. In her spare time, she’s trying to keep her puppy, Jake from eating her out of house and home.Read More
Salvatore (“Salvo”) Alesci, M.D., Ph.D. joined PhRMA in December 2011 as Vice President, Scientific & Regulatory Affairs. In this role, Dr. Alesci serves as the primary expert for PhRMA on scientific and medical issues. He carries overall responsibility for establishing PhRMA as a “go to” source for input on policies and legislation related to innovative approaches to biopharmaceutical discovery and development. Dr. Alesci brings to PhRMA over ten years of combined academia/government/industry research experience and multi-disciplinary expertise in Translational Medicine.Read More
Richard I. Smith is a past Executive Vice President for Policy and Research at the Pharmaceutical Research and Manufacturers of America (PhRMA).
Previously, Rick was Vice President, Public Policy and Research at the American Association of Health Plans; Vice President, Health Policy at the Association of Private Pension and Welfare Plans (now the American Benefits Council); Director, Public Policy at the Washington Business Group on Health (now the National Business Group on Health); and Staff Director of the Maryland Governor’s Commission on Health Care Policy and Financing.Read More
Chester “Chip” Davis, Jr. currently serves as Executive Vice President for Advocacy at PhRMA. In this role Davis is responsible for leading and managing PhRMA’s federal, state and international government relations and advocacy efforts.Read More
Kristin Van Goor is Assistant Vice President of Scientific and Regulatory Affairs at PhRMA. She leads PhRMA’s activities on regulatory and science policy issues ranging from innovative biologics and biosimilars, information technology, benefit-risk assessment, and patient-focused drug development. Kristin is a geneticist by training, having received her doctorate from Yale University and completing a postdoctoral fellowship in the Cancer Genetics Branch of the National Human Genome Research Institute. When away from the office, she enjoys dancing, improving her skills at pairing wine andRead More
Jeff Francer is Vice President and Senior Counsel at PhRMA and serves as principal counsel to the association on issues relating to the research, development, and regulation of medicines in the US and globally. Prior to joining PhRMA, Jeff served as Associate Chief Counsel of the FDA and as a regulatory attorney for biopharmaceutical companies. Jeff is also an avid Red Sox fan.Read More
Robert Zirkelbach is Senior Vice President of Communications at PhRMA. He joins PhRMA in 2014 after working for seven years representing the health insurance industry. He likes Saturday afternoon BBQs on his deck, traveling, trying new restaurants, and attempting to play golf. He’s an avid, somewhat obsessive, Iowa Hawkeye fan and is lucky to have a wife that loves watching college football on Saturday afternoons. Follow Robert on Twitter @robzirk.Read More
Ally is a Director of Communications at PhRMA focusing on Medicare, Medicaid, the Affordable Care Act, and other public programs. Her previous experience includes leading health communications for a large membership organization, supporting public affairs clients, and working for the governor of Louisiana. Ally enjoys travel, trying new restaurants and spending time with Buddy, her 9-year-old rescue Pomeranian. In the fall, she and her husband are almost always wearing Saints gear. Follow Ally on Twitter @AllyFunk.Read More
Brooke Ringel is an Associate Vice President for International Affairs at PhRMA, where she focuses on global intellectual property and trade policy and advocacy. Prior to joining PhRMA in June 2013, Brooke practiced international trade law at Kelley Drye & Warren LLP in Washington, specializing in export control and compliance. Brooke has a BA from Stanford University in Political Science/International Affairs and graduated with honors from the George Washington University Law School.Read More
Holly Campbell is a Director of Communications at PhRMA focusing on the value of medicines, the research and development process, and payment and delivery reform. Prior to joining PhRMA, Holly worked for large and small large public relations firms where she provided strategic communications counsel, media relations and partnership expertise to health care and pharmaceutical clients. In her free time, she enjoys taking barre classes, trying new restaurants and spending time with Boss and Poppy, her rescue pups. Follow Holly on Twitter at @Hlcampbe.Read More